Overview
Anticipate, distinguish and manage prolonged postoperative mineral uptake after parathyroid surgery while protecting against acute symptomatic hypocalcaemia.
Longstanding PTH excess accelerates bone turnover. Once the source is removed, osteoblast-driven mineralisation can dominate and draw calcium, phosphate and magnesium from extracellular fluid into previously demineralised bone. The fall may begin in the first postoperative days and persist for weeks or longer, distinguishing hungry bone from a brief operative nadir. It is particularly relevant after surgery for severe primary, secondary or tertiary hyperparathyroidism.
Clinical severity reflects the absolute calcium, speed of decline, magnesium, acid–base state and cardiac or neurological vulnerability. Neuromuscular irritability can progress from paraesthesia and cramps to tetany, bronchospasm, laryngospasm, seizure and arrhythmia. The absence of symptoms does not make a falling postoperative trajectory safe, especially when monitoring or medicine access will become less reliable after discharge.
Calcium replacement must be individualised rather than prescribed as a universal schedule. Calcium salt, active vitamin D choice and dose depend on surgery, renal function, dialysis, phosphate, magnesium, gastrointestinal absorption and local product availability. Renal and endocrine specialists should lead high-dose or prolonged therapy, with the current Society for Endocrinology emergency guidance, SmPC and organisation protocol at the bedside.